Elekta (OTCMKTS:EKTAY – Get Free Report) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports. Get Elekta alerts:Elekta (OTCMKTS:EKTAY – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. As a group, research analysts predict that Elekta will post 0.43 earnings per share for the current year. About ElektaElekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Further ReadingReceive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.